Dr. Sridevi Khambhampaty Resigns as CEO of Shilpa Biologicals Pvt Ltd
Shilpa Medicare Limited announced the resignation of Dr. Sridevi Khambhampaty from her position as Chief Executive Officer (CEO) of its material subsidiary, Shilpa Biologicals Private Limited. The change in leadership is effective from closing hours of July 15, 2026.Dr. Sridevi Khambhampaty stepped down from the role due to personal commitments. She had held the position since April 15, 2026.
Shilpa Biologicals Private Limited is a material subsidiary of Shilpa Medicare Limited. The cessation of Dr. Khambhampaty's duties marked her last day as CEO.
Key details regarding the change in senior managerial personnel are presented below:
| Personnel Name | Role | Date of Appointment | Date of Cessation | Reason for Change |
|---|---|---|---|---|
| Dr. Sridevi Khambhampaty | Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited | April 15, 2026 | July 15, 2026 | Resignation due to personal commitments |
SHILPAMED Stock Price Movement
Shilpa Medicare Limited gained strongly in post-market trading today, with shares closing at ₹645.75 after rallying 3.44%. The stock achieved its 52-week high and traded a total volume of 741,076 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.